stimulant
Showing 1 - 25 of 802
Leveraging Psychological Autopsies to Accelerate Research Into
Recruiting
- Stimulant Overdose
- +3 more
-
San Francisco, CaliforniaSan Francisco Department of Public Health
Oct 6, 2023
The Longitudinal Study of Stimulant Use Disorder
Not yet recruiting
- Stimulant Use
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 3, 2023
Stimulant Use Trial (Health Education plus Incentives for Abstinence, Health Education)
Not yet recruiting
- Stimulant Use
- Health Education plus Incentives for Abstinence
- Health Education
- (no location specified)
Mar 15, 2023
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk
Recruiting
- Stimulant Abuse
- Criminal Behavior
- Decision task
-
Albuquerque, New MexicoThe Mind Research Network
Apr 25, 2023
Stimulant Overdose in Medicaid Population: Who is at Risk, and
Active, not recruiting
- Stimulant Overdose
- Aim 1 (case-cohort study)
- +2 more
-
Philadelphia, PennsylvaniaUNIVERSITY OF PENNSYLVANIA Perelman SCHOOLS OF MEDICINE
Aug 4, 2023
ADHD Trial in New York (Guanfacine, Lisdexamfetamine)
Terminated
- Attention Deficit Hyperactivity Disorder
-
New York, New YorkNew York State Psychiatric Institute
Jan 18, 2023
ADHD, Stimulant Use, Working Memory Trial in Laramie (Adderall IR 10mg, Placebo)
Recruiting
- Attention Deficit Hyperactivity Disorder
- +4 more
- Adderall IR 10mg
- Placebo
-
Laramie, WyomingUniversity of Wyoming
Jan 18, 2023
Stimulant Use and Methylation in HIV
Completed
- HIV Infections
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 14, 2023
HIV Trial in Miami (reSET, Standard of care)
Not yet recruiting
- HIV Infections
- reSET
- Standard of care
-
Miami, FloridaUniversity of Miami
Jul 14, 2023
Opioid Use Disorder, Stimulant Use Disorder Trial in Baltimore (Suvorexant (dual orexin receptor antagonist), Placebo)
Recruiting
- Opioid Use Disorder
- Stimulant Use Disorder
- Suvorexant (dual orexin receptor antagonist)
- Placebo
-
Baltimore, MarylandBehavioral Pharmacology Research Unit at the Johns Hopkins Bayvi
Dec 13, 2022
Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)
Not yet recruiting
- Stimulant Use
- +3 more
- Contrave 8Mg-90Mg Extended-Release Tablet
- Bupropion
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 31, 2022
ADHD, ADHD Trial in New York (Methylphenidate, Atomoxetine)
Recruiting
- ADHD
- Attention Deficit Hyperactivity Disorder
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 5, 2022
ADHD Trial in Omaha (methylphenidate)
Completed
- Attention Deficit Hyperactivity Disorder
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Sep 16, 2022
Stimulant Medication on Loss of Control Eating in Youth With
Not yet recruiting
- Loss of Control Eating
- Attention Deficit/Hyperactivity Disorder
- (no location specified)
Oct 19, 2022
Opioid Use Disorder, Stimulant Use Disorder Trial in Minneapolis (Contingency Management)
Recruiting
- Opioid Use Disorder
- Stimulant Use Disorder
- Contingency Management
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 15, 2022
Stimulant Use, Substance Use Disorders Trial in Indianapolis (Virtual Reality)
Recruiting
- Stimulant Use
- Substance Use Disorders
- Virtual Reality
-
Indianapolis, IndianaIndiana University School of Medicine - Goodman Hall
Apr 19, 2023
Methamphetamine Use Disorder Trial in Denver (care navigation)
Recruiting
- Methamphetamine Use Disorder
- care navigation
-
Denver, ColoradoDenver Health
Sep 11, 2023
Stimulant Use Disorder, Substance-related Disorders Trial in Palo Alto (Repetitive transcranial magnetic stimulation (rTMS))
Recruiting
- Stimulant Use Disorder
- Substance-related Disorders
- Repetitive transcranial magnetic stimulation (rTMS)
-
Palo Alto, CaliforniaVA Palo Alto Health Care System, Palo Alto, CA
Feb 24, 2022
Cocaine Use Disorder, Methamphetamine Abuse, Cocaine Dependence Trial in United States (rTMS, Sham (Placebo))
Recruiting
- Cocaine Use Disorder
- +8 more
- rTMS
- Sham (Placebo)
-
Winston-Salem, North Carolina
- +3 more
Feb 16, 2022
Attention Deficit/Hyperactivity Disorder Trial in Boston (SMS Intervention)
Active, not recruiting
- Attention Deficit/Hyperactivity Disorder
- SMS Intervention
-
Boston, MassachusettsMassachusetts General Hospital
Sep 22, 2022
Cognitive Function, Video Gamers Trial in College Station (Phaeosol low dose, Phaeosol high dose, Placebo)
Completed
- Cognitive Function
- Video Gamers
- Phaeosol low dose
- +2 more
-
College Station, TexasExercise & Sport Nutrition Lab
Sep 22, 2022
Stimulant Use (Diagnosis) Trial in United States (Science to Service Laboratory)
Not yet recruiting
- Stimulant Use (Diagnosis)
- Science to Service Laboratory
-
Bristol, Connecticut
- +9 more
Jan 26, 2023
Stimulant Use, Contingency Management Trial (Contingency Management)
Not yet recruiting
- Stimulant Use
- Contingency Management
- Contingency Management
- (no location specified)
Oct 15, 2021
Attention Deficit/Hyperactivity Disorder Trial in Boston (SMS Intervention)
Recruiting
- Attention Deficit/Hyperactivity Disorder
- SMS Intervention
-
Boston, MassachusettsMassachusetts General Hospital
May 25, 2022